VERU Veru Inc

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G/A

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

 

Veru Inc.

(Name of Issuer)

 

Common stock, par value $0.01 per share (“Common Stock”)

(Title of Class of Securities)

 

92536C103

(CUSIP Number)

 

January 16, 2024

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨	Rule 13d-1(b)

 

x	Rule 13d-1(c)

 

¨	Rule 13d-1(d)

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

1.	Names of Reporting Persons   Phillip Frost, M.D.
2.	Check the Appropriate Box if a Member of a Group (See Instructions)   (a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization   United States

 

Number of Shares Beneficially Owned By Each Reporting Person With:	5.	Sole Voting Power   0
	6.	Shared Voting Power   5,100,253(1)
	7.	Sole Dispositive Power   0
	8.	Shared Dispositive Power   5,100,253(1)

 

9.	Aggregate Amount Beneficially Owned by Each Reporting Person   5,100,253 (1)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares ¨
11.	Percent of Class Represented by Amount in Row (9)   3.5%(2)
12.	Type of Reporting Person (See Instructions)   IN

 

(1)

Includes 5,100,253 shares of Common Stock of the Issuer held by Frost Gamma Investments Trust (“FGIT”), of which Dr. Phillip Frost is the trustee of FGIT. Frost Gamma L.P. is the sole and exclusive beneficiary of FGIT. Dr. Phillip Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc. and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Phillip Frost is also the sole shareholder of Frost-Nevada Corporation.

 

(2)	The calculation of all percentages set forth herein is based on 146,381,186 shares of Common Stock outstanding as of January 16, 2024, as reported on the Issuer’s Proxy Statement, and filed with the Securities and Exchange Commission on Schedule 14A on January 26, 2024.

 

 

1.	Names of Reporting Persons   Frost Gamma Investments Trust
2.	Check the Appropriate Box if a Member of a Group (See Instructions)   (a) ¨ (b) x
3.	SEC Use Only
4.	Citizenship or Place of Organization   Florida

 

Number of Shares Beneficially Owned By Each Reporting Person With:	5.	Sole Voting Power   0
	6.	Shared Voting Power   5,100,253(1)
	7.	Sole Dispositive Power   0
	8.	Shared Dispositive Power   5,100,253(1)

 

9.	Aggregate Amount Beneficially Owned by Each Reporting Person   5,100,253 (1)
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares ¨
11.	Percent of Class Represented by Amount in Row (9)   3.5%
12.	Type of Reporting Person (See Instructions)   OO

 

(1)

Includes 5,100,253 shares of Common Stock of the Issuer held by FGIT, of which Dr. Phillip Frost is the trustee of FGIT. Frost Gamma L.P. is the sole and exclusive beneficiary of FGIT. Dr. Phillip Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc. and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Phillip Frost is also the sole shareholder of Frost-Nevada Corporation.

 

 

Item 1(a).	Name of Issuer
	Veru Inc. (the “Issuer”)

 

Item 1(b).	Address of the Issuer’s Principal Executive Offices
	2916 N. Miami Avenue, Suite 1000, Miami, Florida 33127

 

Item 2(a).	Names of Persons Filing
	Phillip Frost, M.D.
	Frost Gamma Investments Trust

 

Item 2(b).	Address of the Principal Business Office, or if none, Residence:
	Dr. Phillip Frost - 4400 Biscayne Blvd. Miami, FL 33137
	Frost Gamma Investments Trust - 4400 Biscayne Blvd. Miami, FL 33137

 

Item 2(c).	Citizenship
	Phillip Frost, M.D. - United States
	Frost Gamma Investments Trust is organized under the laws of State of Florida

 

Item 2(d).	Title of Class of Securities
	Common stock, par value $0.01 per share

 

Item 2(e).	CUSIP Number
	92536C103

 

Item 3.

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

¨	(a) Broker or Dealer registered under Section 15 of the Exchange Act.
¨	(b) Bank as defined in Section 3(a)(b) or the Exchange Act.
¨	(c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.
¨	(d) Investment company registered under Section 8 of the Investment Company Act.
¨	(e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).
¨	(f) An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).
¨	(g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).
¨	(h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.
¨	(i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.
¨	(j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).
x	Not applicable

 

 

Item 4.

Ownership

 

The responses to Items 5-11 of the cover pages of this Schedule 13G are incorporated herein by reference.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)	Amount Beneficially Owned:

Phillip Frost, M.D. – 5,100,253

Frost Gamma Investments Trust – 5,100,253

 

(b)	Percent of Class:

Phillip Frost, M.D. – 3.5%

Frost Gamma Investments Trust – 3.5%

 

The calculation of all percentages set forth herein is based on 146,381,186 shares of Common Stock outstanding as of January 16, 2024, as reported on the Issuer’s Proxy Statement, filed with the Securities and Exchange Commission on Schedule 14A on January 26, 2024.

 

(c)	Number of shares as to which such person has:

 

(i)	sole power to vote or to direct the vote:
	Phillip Frost, M.D. – 0
	Frost Gamma Investments Trust - 0

 

(ii)	shared power to vote or to direct the vote:
	Phillip Frost, M.D. – 5,100,253(1)
	Frost Gamma Investments Trust – 5,100,253

 

(iii)	sole power to dispose or to direct the disposition of:
	Phillip Frost, M.D. – 0
	Frost Gamma Investments Trust - 0

 

(iv)	shared power to dispose or to direct the disposition of:
	Phillip Frost, M.D. – 5,100,253(1)
	Frost Gamma Investments Trust – 5,100,253

 

(1)

Includes 5,100,253 shares of Common Stock held as of the date hereof by Frost Gamma Investments Trust (“FGIT”), of which Dr. Phillip Frost is the trustee of FGIT. Frost Gamma L.P. is the sole and exclusive beneficiary of FGIT. Dr. Phillip Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc. and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Phillip Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

 

Item 5.

Ownership of Five Percent or Less of a Class

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following x.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

 

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

 

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group

 

Not Applicable

 

 

Item 9.

Notice of Dissolution of Group

 

Not Applicable

 

Item 10.

Certification

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 6, 2024	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Phillip Frost, M.D., Individually
	FROST GAMMA INVESTMENTS TRUST
Dated: February 6, 2024	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Trustee

 

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations

(See 18 U.S.C. 1001)

 

 

 

EXHIBIT INDEX

 

Exhibit 1 Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

 

 

Exhibit 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of Veru Inc., a Wisconsin corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

 

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

 

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

 

IN WITNESS WHEREOF, the undersigned have executed this agreement as of February 6, 2024.

 

	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Phillip Frost, M.D., Individually
	FROST GAMMA INVESTMENTS TRUST
	By:	/s/ Phillip Frost, M.D.
	Name:	Phillip Frost, M.D.
	Title:	Trustee

 

 

 

---